Singing Scientist Quite Frankly Committed to Cystic Fibrosis Cure
CINCINNATI - He does good research and he sings Sinatra, and he uses both talents to benefit people who suffer from the lung-clogging, asphyxiating disease cystic fibrosis.
Daniel Hassett, PhD, of UCs molecular genetics, biochemistry and microbiology department, isnt your average-looking associate professor. He invariably wears a baseball cap and cowboy boots in his lab, and his hair is more long over the shoulders than short over the ears.
But his work isnt average, either. Nor his commitment to raising money to fund cystic fibrosis research.
Every year Dr. Hassett sings his favorite Sinatra melodies, accompanied by a 15-member orchestra, at a Cystic Fibrosis Foundation fundraiser in Milwaukee, a show that pulls in $100,000 to $200,000 in donations.
Last month, thanks to recognition he earned from his latest research, he was invited to a fundraiser in Tennessee, where the organizers promised him a $10,000 check to support his own cystic fibrosis studies. Dr. Hassett made a speech, belted out some Sinatra numbers to a standing ovationwhich earned him another $5,000 from a woman in the audienceand then upped the research funding ante another $4,000 by auctioning off his Fight Cystic Fibrosis baseball cap.
Thats the easy part. The tough stuff is done in a lab at UCs Academic Health Center, where Dr. Hassett has just discovered what might be the Achilles heel of the bug that kills cystic fibrosis patients. The organism,
Pseudomonas aeruginosa,
has a fatal flaw that leaves the organism vulnerable to destruction by a common food preservative.
It has been known for some time that
Pseudomonas aeruginosa
grows within the deadly, lung-clogging mucous found in the airways of cystic fibrosis patients, and significantly weakens them.
Dr. Hassetts study suggests, however, that a mutation in the organismknown as mucAalso represents a fatal flaw that could help physicians clear the characteristic goop from the lungs of advanced cystic fibrosis patients.
The finding is reported in the February 2006 edition of the
Journal of Clinical Investigation
by a 15-member U.S. and Canadian research team led by Dr. Hassett, and funded by the U.S. National Institutes of Health, the Cystic Fibrosis Foundation and the U.S. Department of Energy.
The reason for optimism, the researchers say, is that the same genetic change that turns
Pseudomonas aeruginosa
into a sticky, antibiotic-resistant killer also leaves it susceptible to destruction by slightly acidified sodium nitrite, a common chemical that is widely used in the curing of lunch meat, sausages and bacon.
We believe that we have discovered the Achilles heel of the formidable mucoid form of
Pseudomonas aeruginosa,
which could lead to improved treatment for cystic fibrosis airway disease, said Dr. Hassett. We can essentially say that this organism, which some people thought could never be beaten, can now be destroyed by nothing more exotic than a common food preservative.
Cystic fibrosis, which affects about 30,000 people in the United States, mostly Caucasians of north European origin, is an inherited disease caused by a defect in a gene called the cystic fibrosis transmembrane conductance regulator (CFTR). Affecting the airways and many other vital organs and processes, cystic fibrosis is chronic, progressive and ultimately fatal, mostly as a result of respiratory failure.
The lung-clogging, suffocating mucoid form of Pseudomonas aeruginosa essentially is a death sentence for cystic fibrosis patients because these bacteria are inherently antibiotic and white-cell resistant, said Dr. Hassett.
Until the 1980s, most deaths from cystic fibrosis occurred in children and teenagers. Today, thanks to improved treatments, people with cystic fibrosis live an average of 35 years.
During the chronic form of cystic fibrosis, Dr. Hassett said, the mutated form of the organism, combined with the immune systems attempts to fight it off, wreaks havoc in the lungs.
When
Pseudomonas aeruginosa
invades the mucous thats built up in the airways, said Dr. Hassett, it forms a resistant biofilm, like that which occurs on teeth or a toilet bowl, and divides rapidly.
White cells from our immune system try to get in there to fight off the invaders, he added, but they cant reach the bacteria to kill them because theyre enmeshed in that thick mucous, essentially a human form of quicksand. So in trying to defend the body against the
Pseudomonas aeruginosa,
the white blood cells end up dumping toxic, damaging material onto the airway surfaces, which leads to lung destruction.
This biofilm lines the whole area, getting thicker and thicker and developing into a dense layer that deprives surface tissue of oxygen, ultimately killing it. So its not only the bacteria that contribute to the disease, its also our own immune system.
The good news is that Dr. Hassett and his colleagues found that about 87 percent of the mucoid
Pseudomonas
organisms they studied have a fatal flaw in the very gene (mucA) that makes it mucoid as well as antibiotic and immune-system resistantthey are easily destroyed by slightly acidified (pH 6.5) sodium nitrite.
Part of the problem with early and chronic cystic fibrosis, Dr. Hassett explained, is that patients with these conditions make very little nitric oxide, a derivative of acidified sodium nitrite.
Mucoid Pseudomonas aeruginosa bacteria should have enzymes that are able to dispose of both nitrite and nitric oxide, Dr. Hassett said, but for whatever reason, this particular bug doesnt make them, or has very low levels of them.
Thats the fatal flaw in mucoid
Pseudomonas aeruginosa
.
Dr. Hassett and his colleagues had worked on the hypothesis that the mucoid bacteriabecause they flourish in patients who are essentially drowning in their own airway mucouswould grow better using nitrate or nitrite as an alternative to the missing oxygen. But when they tested nonmucoid and mucoid forms, the nonmucoids grew with both nitrate and nitrite without oxygen, while the mucoid organism grew only with nitrate, yet died with nitrite.
The team took about 60 mucoid bacteria from six different clinics in the United States and Canada and found that of all the strains that were mucoid, the ones that had mucA mutations were all sensitive to nitrite, and those that are notoriously antibiotic resistant were even more sensitive.
Sodium nitrite kills the mucoids, and if nonmucoids or other bacteria are present in the airways, it inhibits their growth too, said Dr. Hassett.
When we add slightly acidified sodium nitrite to a suspension containing mucoid bacteria, its converted to the gas nitric oxide, said Dr. Hassett. The mucoid bacteria cant dispose of the nitrite metabolically, and also have difficulty handling the gas, so they die.
Here was something we hypothesized that would allow mucoid bacteria to grow much better than nonmucoid bacteria, but instead it killed them, said Dr. Hassett. In plain English, these bacteria had a defect that we didnt anticipate. Ive never been so happy in my life to be wrong!
Sodium nitrite, Dr. Hassett said, has potential as a time-release capsule for cystic fibrosis patients. Because the nitrite is degraded very slowly, and mucoid bacteria cant get rid of it, it should specifically kill mucoid organisms that have the mucA mutationwhich most do.
Dr. Hassett said he envisions sodium nitrite could be used in aerosol form to treat mucoid Pseudomonas aeruginosa in cystic fibrosis lung disease.
This wouldnt need to be a long-term treatment, he said. Once a patient acquires mucoids, which commonly occur, the physician would simply use sodium nitrite and monitor how many mucoid bacteria are still in airway sputum. Once the mucoid organisms are killed, and the patient starts showing signs of improvement, treatment would continue with conventional antibiotics.
But bringing this treatment to the bedside wont be easy, Dr. Hassett conceded.
Right now, we dont see the Food and Drug Administration approving blowing sodium nitrite into peoples airways, because it may potentially have some toxic side effects.
However, nitrites are used clinically, to counteract cyanide poisoning, warts and athletes foot, for example. And in neonatal pulmonary hypertension, physicians may be using nitrite doses nearly 60 times higher than we use to kill the organism in mouse and human airway cells.
Key researchers on the 15-member research team with Dr. Hassett were San Sun Yoon, formerly with the University of Cincinnati and now at Harvard Medical School, Sergei Lymar, Brookhaven National Laboratory, and Richard Boucher, University of North Carolina.
Tags
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
Put down that beer; it's not a tanning lotion
July 1, 2024
The University of Cincinnati's Kelly Dobos joined WVXU's Cincinnati Edition to discuss what's fact and what's myth when it comes to sunscreen use, different kinds of sunscreen and a social media recommendation to use beer on your skin to help get a tan.
Cincinnati researchers want to know if MRIs can work better
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.